AMLX Amylyx Pharmaceuticals Inc

$AMLX typical trading post highly anticipated data and market busy with much macro. keep focused and you will.see the 7bln-8bln market cap sooner than later! had same with other stocks that even with a smaller and less lucrative pipeline than the one Amylyx enjoys. Enjoy the weekend. usd 70-80 coming.

$AMLX we are potentially seeing same buyer that stepped in yesterday. The volume in the close was phenomenal without any index related. target 70 (100 with ALS).

$AMLX new U.S. ICD-10-CM code for post-bariatric hypoglycemia (PBH)—the condition relevant to Amylyx's avexitide—then yes: it became effective today, October 1, 2026. The new code is E89.830 — Post bariatric hypoglycemia. It is part of the FY2027 ICD-10-CM code set, which applies to services from October 1, 2026 through September 30, 2027. CMS +2 That's significant for PBH because previously clinicians generally had to use broader hypoglycemia codes such as E16.1 (Other hypoglycemia) together with bariatric-surgery status. The CDC proposal specifically noted that this did not accurately identify PBH patients. Target 70 (with ALS and Wolfram target 100)

$AMLX This current situation is all wrong…. Were these institutions that own 95% of AMLX …are constantly lending out their shares to short. From the perspective of a long shareholder, it’s completely backwards: …”If you’re invested alongside me because you believe the shares have value, why are you collecting a lending fee to provide ammunition to somebody betting on the opposite outcome?” And even when AMLX gets constructive analyst commentary this morning, …including a $45 Stifel target …..we STILL see a constant sell off. AMLX is doing great …..and none of this downtrend is related to the company operations…… it’s directly related to the very institutions that claim they’re backing the company.

$AMLX For the love of God, would y’all please stop shorting this company…. They now have life-changing products …and all you “shorts” just wanna beat it down . And that goes directly to all you institutional investors here ….as you keep lending your shares out to short …shame on every one of you ..😡 I hope ALL “shorts” get burned here very soon 

$AMLX Who the fuc is putting this CONSTANT down Pressure on this Stock? There are zero negative issues with the company In fact, their war chest is setting on over $700MILLION dollars now. There were some Tax sales that were automated with some of the institutional holders, but that in itself does NOT answer nearly any of this Somebody is manipulating the fuc out of this …and has dropped it over $10 in the last 30 days 

$AMLX whom ever buys this stock is smart whom ever sells either needs money or is an idiot !

$AMLX Good Morning ☕️ Yesterday at JPM. Not just Avexitide. ASO. $100 plus . Josh- AMX114 is an ASO targeting Calpain-2. So Calpain-2 is a protease that's involved in basically breaking down the cytoskeleton when a nerve's axon degenerates and dies. It's been shown to be associated and activated in multiple neurodegenerative diseases. There's genetic data linking it to ALS. So trial ongoing, a multiple ascending dose, placebo controlled study in people living with ALS. Because it's a protease, there are known things that Calpain-2 cleaves, some of which can be measured in the CSF. So we'll be measuring those and tracking biomarkers, both to look at biologic target engagement, but there are also some biomarkers such as neurofilament light, we will look at for kind of disease engagement as well. So we're quite excited about that program and we should have more biomarker data in the coming months and quarters.

$AMLX Conservative revenue of 3 Billion. Conservative multiple of 3. 10 Billion market cap here soon.